UFP Technologies, Inc.
At today's price, UFP Technologies, Inc. (UFPT) is priced for +18.5% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• UFP Technologies makes custom engineered components for medical-device makers, in markets like minimally invasive surgery, orthopedics, and wound care, and the business has shifted decisively toward medical, which reached $143.4 million of Q1 2026 sales, up 5.9% [Source: UFPT Q1 2026 results, May 4 2026]. • The defining customer relationship is Intuitive Surgical: UFP extended and expanded its supply agreement through December 31, 2029 [Source: UFPT disclosures, February 2026], adding contract
Is UFPT overvalued? See what's priced in →
262 institutional managers reported holding UFPT in 13F filings for the quarter ended 2026-03-31. 32 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 1.2M shares were sold short as of the 2026-06-15 count, about 16% of shares outstanding (5.9 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
UFPT's share count grew 2.6% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at UFPT over the trailing three years: 2023: 2 buys totaling $53k; 2025: 1 buy totaling $92k. 12 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
UFPT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-03-17 | -2.8% | +37.3% |
| 2023-05-11 | +5.8% | +25.1% |
| 2023-08-10 | -2.2% | -12.3% |
| 2023-11-10 | +2.1% | +17.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
UFPT's latest 8-K filings: 2026-06-10 (items 5.02, 7.01, 9.01); 2026-06-08 (items 7.01, 9.01); 2026-06-05 (items 5.07); 2026-05-26 (items 5.02); 2026-05-04 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.